Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion type Assertion NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_head.
- NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion description "[They further suggest that the targeting of survivin has the potential to overcome EGFR-TKI resistance in EGFR mutation-positive NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_provenance.
- NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion evidence source_evidence_literature NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_provenance.
- NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion SIO_000772 22075159 NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_provenance.
- NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion wasDerivedFrom befree-2016 NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_provenance.
- NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_assertion wasGeneratedBy ECO_0000203 NP937983.RAFBQFh9uyVIae13rwls21WGCIr3ZvVLymaz5hViRv8TI130_provenance.